Overview

The Comparability of Bispectral Index and Neurosense During Anesthesia

Status:
Terminated
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The assessment of anesthesia depth was based, until recently, on the evolution of hemodynamic parameters. Nowadays it can be evaluated by several monitoring methods, derived from electroencephalogram analysis, namely the Bispectral Index (Aspect Medical Systems, Newton, USA). A new modality is currently under development: the NeuroSENSE (Cleveland Medical Devices Inc., Cleveland, OH 44103, USA). The goal of this study is to compare both monitoring modalities during anesthesia.
Details
Lead Sponsor:
Hopital Foch
Treatments:
Anesthetics
Atracurium
Propofol
Remifentanil
Sevoflurane